Clinical evaluation is no longer merely a regulatory requirement to obtain a CE mark: it is the defining factor for the credibility and market viability of a medical device. 

In an increasingly demanding regulatory environment, clinical evaluation has evolved from a routine procedure into the true measure of a device's scientific robustness. It is no longer enough to claim compliance—manufacturers must demonstrate with clear, traceable evidence that the device is safe and performs as intended under real-world conditions of use. 

However, many organizations continue to overlook a critical element. A silent yet decisive factor that makes the difference between a robust clinical evaluation and one vulnerable to audit findings: the Clinical Evaluation Report (CER). Under Regulation MDR 2017/745, the level of scrutiny has changed the rules of the game. The quality, currency, and traceability of clinical evidence are non-negotiable.

In this article, we explain why systematic literature review reports are key to clinical evaluation and how they can have a direct impact on regulatory compliance and obtaining CE marking.

What does the MDR truly demand for clinical evaluation?

Regulation (EU) 2017/745 on Medical Devices explicitly requires manufacturers to establish, document, and maintain a continuous clinical evaluation process throughout the entire lifecycle of a device. This framework revolves around two core deliverables:

  • The Clinical Evaluation Plan (CEP): Defines the methodology, clinical endpoints, and information sources to be used.
  • The Clinical Evaluation Report (CER): Consolidates all available clinical data regarding device safety and performance.

Furthermore, during the post-market phase, manufacturers must implement a Post-Market Clinical Follow-up (PMCF) plan and update the CER periodically—annually for Class IIb and Class III devices—incorporating all relevant scientific evidence published since the previous review.

The MEDDEV 2.7/1 Rev. 4 guidance and MDCG (Medical Device Coordination Group) guidelines outline how literature searches must be executed within this framework: using explicit search strings, defined databases, logged search outputs, and a reproducible, traceable methodology.

The Challenge of literature searches: far beyond a PubMed query

At first glance, conducting a literature search might seem straightforward. However, within the context of a medical device clinical evaluation, the complexity is significant. A rigorous systematic search requires:

  • Formulating precise search strings, Boolean operators, and MeSH terms.
  • Querying multiple scientific databases (e.g., PubMed, Embase, Cochrane).
  • Evaluating literature for the subject device and justified equivalent devices.
  • Identifying and analyzing the State of the Art (SOTA) for the relevant clinical condition.
  • Documenting and justifying explicit inclusion and exclusion criteria.
  • Tracking emerging publications that could alter the benefit-risk profile.

This entire process must be captured in an audited, reproducible literature search report aligned with MDR expectations. Any gap in this documentation can trigger critical non-conformities during Notified Body reviews, delaying CE mark certification or renewal.

Continuous updates: a major operational bottleneck

One of the most demanding aspects of clinical evaluation under the MDR is its dynamic, ongoing nature. Scientific evidence evolves, new clinical studies are published, safety alerts emerge, harmonized standards are updated, and literature on alternative therapies grows continuously.

Organizations managing these searches manually face a major operational burden: repeatedly allocating internal scientific resources to track, filter, and synthesize dispersed clinical and regulatory data. Without a structured system, this manual approach creates significant risks: outdated documentation, evidence gaps, and audit non-compliance.

ARI: rigorous, efficient regulatory search reports

Ambit Iberia developed ARI (Automated Regulatory Intelligence) to directly address this operational challenge. ARI operates as a specialized intelligence engine that automates the continuous monitoring of regulations, guidelines, and scientific literature relevant to the MedTech sector, delivering structured, objective reports verified by expert consultants.

Within clinical evaluation workflows, ARI enables organizations to:

  • Maintain an up-to-date evidence base supporting the CER by automatically identifying relevant new publications or regulatory updates.

  • Generate literature search reports with defined, reproducible, and fully documented criteria, ready for seamless integration into the technical documentation.

  • Continuously monitor the State of the Art (SOTA), ensuring the clinical evaluation reflects the latest scientific knowledge.

  • Provide objective, traceable evidence verified by specialists, reinforcing documentation rigor before Notified Bodies and competent authorities.

  • Reduce operational burden and costs associated with manual scientific data management.

The result is an agile, better-supported clinical evaluation process backed by a solid technical foundation that withstands regulatory scrutiny.

Quality evidence cannot be improvised

In today's regulatory landscape, where the MDR demands unprecedented levels of clinical evidence, the quality of literature search reports is a key differentiator. It is not just about compliance—it is about scientific credibility and resilience against Notified Body scrutiny.

Leveraging a tool that automates, systematizes, and documents this process with methodological rigor—backed by expert regulatory consultants—marks the difference between a clinical evaluation that passes audit smoothly and one that accumulates non-conformities.

Would you like to find out how ARI can support your clinical evaluation process?

For over 20 years, Ambit Iberia has supported Pharmaceutical, Biotech, and Medical Device companies in achieving regulatory compliance across the entire product lifecycle. 

Contact us today to discover how our ARI service can strengthen your technical documentation and clinical evaluation processes.